ArticleFuture science OA2025
Therapeutic selection for abnormal uterine bleeding with ovulatory dysfunction: a cross-sectional study in Chinese women.
Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the therapeutic selection of abnormal uterine bleeding with ovulatory dysfunction (AUB-O) among Chinese women and analyze the impact of various factors.
methodsThis was a cross-sectional study involving 3527 patients with AUB-O diagnosed by local doctor between 14 and 55 years old. Questionnaire compiled according to the Chinese AUB-O treatment guidelines was used to collect the demographic and therapeutic information.
resultsThe patients were divided into the juvenile group, the reproductive group, and the senior group. The results showed that irregular menstruation (37.6-46.3%), dysmenorrhea (29.9-44.4%), and heavy menstrual bleeding (16.7-32.2%) were the main symptoms in Chinese AUB-O patients. Most of the patients chose to seek help in the Department of General Gynecology (78.6-90.7%). Among the therapeutic options, combined oral contraceptives (COCs) met the treatment expectations with high acceptance among patients (36.6%-52.2%).
conclusionThis study underscores the crucial need to fortify the endocrine diagnostic proficiency of doctors within the Department of General Gynecology. Furthermore, it also indicates that implementing clinical medication education programs for patients could facilitate their correct selection of appropriate therapeutic strategies for AUB-O.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.